These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hepatitis B vaccines: protective efficacy and therapeutic potential. Michel ML; Tiollais P Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485 [TBL] [Abstract][Full Text] [Related]
4. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness. Stephenne J Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187 [TBL] [Abstract][Full Text] [Related]
5. [Vaccination against hepatitis virus B infection. Vaccine from inactivated HBsAg positive plasma or recombinant vaccine?]. Horejsí J Cas Lek Cesk; 1987 Jul; 126(31):981-2. PubMed ID: 2959363 [No Abstract] [Full Text] [Related]
6. The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B. Joung YH; Park SH; Moon KB; Jeon JH; Cho HS; Kim HS Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754367 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel. Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century. Yap SF Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102 [TBL] [Abstract][Full Text] [Related]
9. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance. Theilmann L; Goeser T Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133 [TBL] [Abstract][Full Text] [Related]
12. The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection? Powis JE; Raboud J; Ostrowski M; Loutfy MR; Kovacs C; Walmsley SL J Infect Dis; 2012 May; 205(10):1534-8. PubMed ID: 22448009 [TBL] [Abstract][Full Text] [Related]
13. [Results of an anti-hepatitis-B vaccination in a population at risk]. Stellato M; Carbi S; Tosolini S Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244 [TBL] [Abstract][Full Text] [Related]
15. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. de la Hoz F; Perez L; de Neira M; Hall AJ Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccines. Zuckerman AJ Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911 [TBL] [Abstract][Full Text] [Related]
17. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen. Schellekens H; de Reus A; Peetermans JH; van Eerd PA Postgrad Med J; 1987; 63 Suppl 2():93-6. PubMed ID: 3317363 [TBL] [Abstract][Full Text] [Related]
18. [Prevention of viral hepatitis B in early infancy--hepatitis B vaccine (HBVac)]. Tanabe M; Noguchi H; Tsuzuki K; Minowa S; Tsuyuki M; Tsuji A; Itoh S; Kanoh H; Katoh T; Mizokami M Nagoya J Med Sci; 1984 Mar; 46(1-4):49-54. PubMed ID: 6234469 [No Abstract] [Full Text] [Related]
20. Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects. Ambrosch F; Frisch-Niggemeyer W; Kremsner P; Kunz C; André F; Safary A; Wiedermann G Postgrad Med J; 1987; 63 Suppl 2():129-35. PubMed ID: 3317348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]